Healthcare - Biotechnology - NASDAQ - US
$ 7.32
1.39 %
$ 1.17 B
Market Cap
-3.01
P/E
Price Target
Average
203.96%
Revenue Forecast
Estimate
--11.83%
EBIT
Estimate
5.62%
Net Income
Estimate
21.02%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Novavax, Inc.
Wall Street analysts predict an average 1-year price target for NVAX of $22.2 , with forecasts ranging from a low of $14 to a high of $31 .
NVAX Lowest Price Target
Wall Street Target
14 USD
91.26%
NVAX Average Price Target
Wall Street Target
22.2 USD
203.96%
NVAX Highest Price Target
Wall Street Target
31 USD
323.50%
REVENUE FORECAST
Revenue Forecast Chart NVAX
EBIT FORECAST
EBIT Forecast Chart NVAX
NET INCOME FORECAST
Net Income Chart NVAX